Literature DB >> 3485075

Lymphocyte activation by OKT3: cyclosporine sensitivity and synergism with phorbol ester.

J E Kay, C R Benzie.   

Abstract

Lymphocyte activation by the mitogenic monoclonal antibody OKT3 is less effective than activation by mitogenic lectins such as phytohaemagglutinin (PHA) and concanavalin A (Con A). Activation by OKT3 is also very sensitive to inhibition by cyclosporine (CSA), which selectively inhibits Ca2+-activated steps in the activation process. In addition, the magnitude of the OKT3 response can be raised to that seen with mitogenic lectins by coincubation with phorbol esters (which activate protein kinase C). These observations suggest that OKT3 may deliver efficiently the Ca2+ signal involved in the initiation of lymphocyte activation, and that the comparatively weak overall response is due to a failure to generate a second signal, probably the activation of protein kinase C, as efficiently as the mitogenic lectins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485075      PMCID: PMC1453954     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Stimulation of the T3-T cell receptor complex induces a membrane-potential-sensitive calcium influx.

Authors:  H C Oettgen; C Terhorst; L C Cantley; P M Rosoff
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

2.  Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate.

Authors:  D L Rosenstreich; S B Mizel
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  Synergistic action of phorbol esters in mitogen-activated bovine lymphocytes.

Authors:  A M Mastro; G C Mueller
Journal:  Exp Cell Res       Date:  1974-09       Impact factor: 3.905

4.  Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor.

Authors:  K O'Flynn; A M Krensky; P C Beverley; S J Burakoff; D C Linch
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

5.  Studies on the mechanism of action of cyclosporin A.

Authors:  D Wiesinger; J F Borel
Journal:  Immunobiology       Date:  1980-01       Impact factor: 3.144

6.  OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

Authors:  J P Van Wauwe; J R De Mey; J G Goossens
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

7.  Inhibition of proliferation of a murine myeloma cell line and mitogen-stimulated B lymphocytes by the antibiotic amphotericin B (Fungizone).

Authors:  E V Walls; J E Kay
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

8.  Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.

Authors:  P M Colombani; A Robb; A D Hess
Journal:  Science       Date:  1985-04-19       Impact factor: 47.728

9.  Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester.

Authors:  A Truneh; F Albert; P Golstein; A M Schmitt-Verhulst
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

10.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

View more
  2 in total

1.  Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis.

Authors:  J Devière; C Denys; L Schandene; F Romasco; M Adler; J Wybran; E Dupont
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

2.  T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.

Authors:  C H June; J A Ledbetter; M M Gillespie; T Lindsten; C B Thompson
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.